Parse Biosciences, Inc. (fka Split Biosciences, Inc.)

Democratizing Single Cell Analysis

We are a Seattle-based startup with the mission of accelerating progress in human health and scientific research. At the core of our company is our pioneering approach for single cell sequencing--published in Science in 2018. Single-cell sequencing has already enabled groundbreaking discoveries which have led to new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system. At Parse Bio, we are providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease.